Solbec treatment reaches first milestone

By Staff Reporters

05/10/2004 - 22:00

Solbec Pharmaceuticals has successfully completed the first stage of its Phase 1 clinical trial of its SBP002 compound in the treatment of psoriasis.

To read our articles you will need to either login or subscribe.

Your single user subscription provides more than you think